ShareValue scores for BMX.WAR: Valuation 56, Quality 50, Growth 42, Health 37.

BMX.WAR
GPW

Biomaxima

PLN 9.91(0.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 16%
Valuation
56
Fair Value
Price vs Value
Quality
50
Moderate
Business Strength
Growth
42
Moderate
Revenue & Earnings
Health
37
Stressed
Financial Stability
Momentum
36
Bearish
Price Trend

Company Details

About

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which include real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibiotics, agaroses and molecular biology media, media and buffers for in vitro cultures, phenotypic micromatrices, plastics and small equipment, basic substrate components, and form. In addition, it offers laboratory diagnostics solutions for various areas of clinical chemistry, haematology, coagulology, immunochemistry, POCT, rapid tests, and blood collection systems; and disposable materials comprising microbiology, dispensing equipment, tubes, plugs, tripods, capillaries, equipment, aspiration-vacuum system, containers, tank for analysers, urine analysis, microscope slides, reagent tubes, and autoclave equipment. BioMaxima S.A. was founded in 1997 and is headquartered in Lublin, Poland.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026